1. Retracted: Inhibitory role of large intergenic noncoding RNA‐ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway
   Peng‐Wei Lu et al, 2019, Journal of Cellular Physiology CrossRef
2. Application of Radiosensitizers in Cancer Radiotherapy
   Liuyun Gong et al, 2021, International Journal of Nanomedicine CrossRef
3. Application of nanomedicine in radiotherapy sensitization
   Xiaoyu Song et al, 2023, Frontiers in Oncology CrossRef
4. Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis
   Ying Li et al, 2021, Journal of Drug Targeting CrossRef
5. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance
   Sajad Fakhri et al, 2023, Cancer and Metastasis Reviews CrossRef
6. Downregulation of miR-320 Alleviates Endoplasmic Reticulum Stress and Inflammatory Response in 3T3-L1 Adipocytes
   Lu Liu et al, 2021, Experimental and Clinical Endocrinology & Diabetes CrossRef
7. A MRI-based radiomics model predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma
   Dan Bao et al, 2022, European Radiology CrossRef
8. Magnetic resonance imaging‐based radiomics model for predicting radiation‐induced temporal lobe injury in nasopharyngeal carcinoma after intensity‐modulated radiotherapy
   Dan Bao et al, 2022, Head & Neck CrossRef
9. Modulating the Radiation Response for Improved Outcomes in Breast Cancer
   Andrea M. Pesch et al, 2021, JCO Precision Oncology CrossRef
10. Paradoxical Roles of Carbon Nanotubes in Cancer Therapy and Carcinogenesis
    Bohan Xu et al, 2024, Journal of Nanotheranostics CrossRef
11. The Role of single- and multi-walled Carbon Nanotube in Breast Cancer Treatment
    Babak Faraji Dizaji et al, 2020, Therapeutic Delivery CrossRef
12. Effect of long noncoding RNA CCAT2 on drug sensitivity to 5‐fluorouracil of breast cancer cells through microRNA‐145 meditated by p53
    Ziyun Zhang et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
13. Highlights on molecular targets for radiosensitization of breast cancer cells: Current research status and prospects
    Zhi‐Rui Zhou et al, 2018, Cancer Medicine CrossRef
14. Diagnosis and treatment status of inoperable locally advanced breast cancer and the application value of inorganic nanomaterials
    Linxuan Wu et al, 2024, Journal of Nanobiotechnology CrossRef
15. Biomedical applications of carbon nanotubes: A systematic review of data and clinical trials
    Lucas Rannier M. de Andrade et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
16. Functionalized Carbon Nanostructures Versus Drug Resistance: Promising Scenarios in Cancer Treatment
    Manuela Curcio et al, 2020, Molecules CrossRef
17. E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51
    Pian Liu et al, 2022, Chemico-Biological Interactions CrossRef
18. Fabrication of magnetic nanocomposite as responsive drug delivery vehicle for cervical cancer therapy
    Mahdieh Darroudi et al, 2023, Applied Organometallic Chemistry CrossRef
19. Added value of histogram analysis of ADC in predicting radiation-induced temporal lobe injury of patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy
    Dan Bao et al, 2022, Insights into Imaging CrossRef
20. When Polymers Meet Carbon Nanostructures: Expanding Horizons in Cancer Therapy
    Giuseppe Cirillo et al, 2019, Future Medicinal Chemistry CrossRef